News Releases
Regeneus trebles on back of merger deal (Sydney Morning Herald)
Regeneus trebles on back of merger deal (Sydney Morning Herald)
Apr 5, 2024
Apr 5, 2024
Cambium Bio to enter ASX through backdoor listing via merger with Regeneus to treat dry eye disease
Cambium Bio to enter ASX through backdoor listing via merger with Regeneus to treat dry eye disease
Feb 6, 2024
Feb 6, 2024
Back to Investors and Media
Our Pipeline
Our Science
Investors and Media
About Us
Contact Us
Our Pipeline
Our Science
Investors and Media
About Us
Contact Us